Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Palbociclib | 10 | uM | 3 | 156.25 | 49.48 | 85.00 | 95.75 | 0.8877 | 0.7649 |
| BT-20 | Taxol | 0.01 | uM | 3 | 156.25 | 49.48 | 69.00 | 95.75 | 0.7206 | 0.4179 |
| BT-20 | Palbociclib | 0.1 | uM | 3 | 156.25 | 49.48 | 118.00 | 95.75 | 1.2324 | 1.4906 |
| BT-20 | Methotrexate | 1 | uM | 3 | 156.25 | 49.48 | 88.00 | 95.75 | 0.9191 | 0.8304 |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 136.00 | 95.75 | 1.4204 | 1.8909 | |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 83.00 | 95.75 | 0.8668 | 0.7214 | |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 50.00 | 95.75 | 0.5222 | 0.0111 | |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 71.00 | 95.75 | 0.7415 | 0.4611 | |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 57.00 | 95.75 | 0.5953 | 0.1602 | |
| BT-20 | Taxol | 0.00033113 | uM | 3 | 156.25 | 49.48 | 94.00 | 95.75 | 0.9817 | 0.9616 |
| BT-20 | Methotrexate | 0.01 | uM | 3 | 156.25 | 49.48 | 98.00 | 95.75 | 1.0235 | 1.0494 |
| BT-20 | Omipalisib | 1 | uM | 3 | 156.25 | 49.48 | 31.50 | 95.75 | 0.3290 | -0.3776 |
| BT-20 | Methotrexate | 10 | uM | 3 | 156.25 | 49.48 | 104.00 | 95.75 | 1.0862 | 1.1813 |
| BT-20 | Palbociclib | 1 | uM | 3 | 156.25 | 49.48 | 114.00 | 95.75 | 1.1906 | 1.4020 |
| BT-20 | Methotrexate | 0.31623 | uM | 3 | 156.25 | 49.48 | 106.00 | 95.75 | 1.1070 | 1.2254 |
| BT-20 | Taxol | 0.0031623 | uM | 3 | 156.25 | 49.48 | 67.00 | 95.75 | 0.6997 | 0.3748 |
| BT-20 | Methotrexate | 0.1 | uM | 3 | 156.25 | 49.48 | 77.00 | 95.75 | 0.8042 | 0.5910 |
| BT-20 | Omipalisib | 0.31623 | uM | 3 | 156.25 | 49.48 | 39.00 | 95.75 | 0.4073 | -0.2211 |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 91.00 | 95.75 | 0.9504 | 0.8960 | |
| BT-20 | Palbociclib | 0.31623 | uM | 3 | 156.25 | 49.48 | 88.00 | 95.75 | 0.9191 | 0.8304 |
| BT-20 | Omipalisib | 0.01 | uM | 3 | 156.25 | 49.48 | 104.00 | 95.75 | 1.0862 | 1.1813 |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 136.00 | 95.75 | 1.4204 | 1.8909 | |
| BT-20 | Omipalisib | 0.0033113 | uM | 3 | 156.25 | 49.48 | 140.00 | 95.75 | 1.4621 | 1.9803 |
| BT-20 | Taxol | 0.1 | uM | 3 | 156.25 | 49.48 | 53.00 | 95.75 | 0.5535 | 0.0748 |
| BT-20 | Taxol | 0.001 | uM | 3 | 156.25 | 49.48 | 102.00 | 95.75 | 1.0653 | 1.1373 |